THE ORTHOPEDIC SPECIALTY HOSPITAL — History
CCN 460049 | 3-year financial timeline | COVID resilience: 56/100
🛡️ Public data only — no PHI permitted on this instance.
$89M
Latest Revenue (FY2022)
+4.5%
Revenue CAGR (3yr)
12.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $81M | $93M | $89M | -4.8% | +4.5% |
| Operating Expenses | $71M | $74M | $78M | +5.8% | +4.5% |
| Operating Margin | 12.3% | 21.1% | 12.4% | -41.5% | +0.2% |
| Net Income | $10M | $20M | $11M | -44.3% | +4.8% |
| Licensed Beds | 40 | 40 | 40 | +0.0% | +0.0% |
| Total Patient Days | 1,188 | 870 | 667 | -23.3% | -25.1% |
| Medicare Day % | 24% | 21% | 23% | +6.6% | -2.4% |
| Medicaid Day % | 1% | 1% | 1% | +4.3% | -26.0% |
COVID Impact & Recovery
Resilience Score: 56/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +9.3% ($81M → $89M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▶ Stable
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.5%
This Hospital
+7.6%
State Avg
Latest Margin
12.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $93M | 12.4% |
| FY2024 (proj) | $96M | 12.4% |
| FY2025 (proj) | $100M | 12.5% |